πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 2,639 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 6346607

APAF-1 an activator of caspase-3

The Board of Regents of the University of Texas System Β· Granted Tue Feb 12 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 07 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6342484

Method and compositions for promotion of wound treatment

The Board of Regents of the University of Texas System Β· Granted Tue Jan 29 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 24 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6342221

Antibody conjugate compositions for selectively inhibiting VEGF

The Board of Regents of the University of Texas System Β· Granted Tue Jan 29 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 24 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6342219

Antibody compositions for selectively inhibiting VEGF

The Board of Regents of the University of Texas System Β· Granted Tue Jan 29 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 24 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6342216

Therapy of cancer by insect cells containing recombinant baculovirus encoding genes

The Board of Regents of the University of Texas System Β· Granted Tue Jan 29 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 24 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6337206

Nucleic acid encoding mouse galanin receptor (GALR2)

The Board of Regents of the University of Texas System Β· Granted Tue Jan 08 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 03 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6333313

Clinical use of oxytocin alone or in combination to treat bone disorders

The Board of Regents of the University of Texas System Β· Granted Tue Dec 25 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 20 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6331284

P202 is a tumor suppressor

The Board of Regents of the University of Texas System Β· Granted Tue Dec 18 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 13 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6326356

Suppression of neu overexpression using a mini-E1A gene

The Board of Regents of the University of Texas System Β· Granted Tue Dec 04 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6323226

Treatment of heart disease with cox-2 inhibitors

The Board of Regents of the University of Texas System Β· Granted Tue Nov 27 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6323024

Coxsackie virus vectors for delivery of nucleic acids encoding antigenic or therapeutic pr

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA Β· Granted Tue Nov 27 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6323020

Neutralization-sensitive epitopes of Cryptosporidium parvum

Arizona Board of Regents on Behalf of the University of Arizona Β· Granted Tue Nov 27 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6320027

Nucleotide sequence of the nucleocapsid gene of oropouche virus

The Board of Regents of the University of Texas Β· Granted Tue Nov 20 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6313155

Composition and method for treating macular disorders

The Board of Regents of the University of Texas System Β· Granted Tue Nov 06 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6312694

Cancer treatment methods using therapeutic conjugates that bind to aminophospholipids

The Board of Regents of the University of Texas System Β· Granted Tue Nov 06 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6310190

USPA1 and USPA2 antigens of Moraxella catarrhalis

The Board of Regents of the University of Texas Β· Granted Tue Oct 30 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6309854

Polynucleotides encoding ligands of the neuropeptide receptor HFGAN72

The Board of Regents of the University of Texas System Β· Granted Tue Oct 30 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6309644

Parasitic nematode transglutaminase proteins and uses thereof

The Board of Regents of the University of Texas System Β· Granted Tue Oct 30 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6309352

Real time optoacoustic monitoring of changes in tissue properties

The Board of Regents of the University of Texas System Β· Granted Tue Oct 30 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6309639

Method for inhibiting an inflammatory response using antibodies to P-selectin glycoprotein

The Board of Regents of the University of Oklahoma Β· Granted Tue Oct 30 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6300101

Methods and compositions including a 13kD B. burgdorferi protein

The Board of Regents of the University of Texas System Β· Granted Tue Oct 09 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 04 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6300308

Methods and compositions for inducing autoimmunity in the treatment of cancers

The Board of Regents of the University of Texas System Β· Granted Tue Oct 09 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 04 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6296849

Methods and compositions including a 13kDa B. burgdorferi protein

The Board of Regents of the University of Texas System Β· Granted Tue Oct 02 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 27 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6294650

Inhibition of mammalian telomerase by peptide nucleic acids

The Board of Regents of the University of Texas System Β· Granted Tue Sep 25 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 20 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired